Detection of Redundant Fusion Transcripts as Biomarkers or Disease-Specific Therapeutic Targets in Breast Cancer
2012 · Cancer Research · 93 citations
https://doi.org/10.1158/0008-5472.can-11-3142
S
Sarah A. McLaughlin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
1.7K
Citations
22
h-index
28
i10-index
Sarah A. McLaughlin is an academic researcher from Jacksonville College. The author has contributed to research in topics: Breast Cancer Treatment Studies & Breast Lesions and Carcinomas & Breast Implant and Reconstruction. The author has an h-index of 22, co-authored 80 publications.
Papers by this author
worksActive Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ
2024 · JAMA · 58 citations
https://doi.org/10.1001/jama.2024.26698
Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy
2015 · Breast Cancer Research and Treatment · 29 citations
https://doi.org/10.1007/s10549-015-3545-6
Pre-treatment peripheral blood immunophenotyping and response to neoadjuvant chemotherapy in operable breast cancer
2024 · Breast Cancer Research · 4 citations
https://doi.org/10.1186/s13058-024-01848-z
Melanoma-Derived Extracellular Vesicles Induce CD36-Mediated Pre-Metastatic Niche
2024 · Biomolecules · 4 citations
https://doi.org/10.3390/biom14070837
Methods workflow for HER2 transcriptomic network.
2015 · Figshare · 0 citations
https://doi.org/10.1371/journal.pone.0079298.g001
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat